The Effects of Antimicrobial Peptide Nal-P-113 on Inhibiting Periodontal Pathogens and Improving Periodontal Status

Table 1

Baseline demographic and clinical characteristics.

Group	Number	Age/years	Sex		PD		CAL		BI
		(mean ± SD)			(mean ± SD)		(mean ± SD)		(mean ± SD)
			male	female	experimental	control	experimental	control	experimental	control
Split-mouth clinical trial	37	35.78 ± 10.70	19	18	5.45 ± 1.58	5.58 ± 1.50	3.12 ± 1.29	3.15 ± 1.25	3.00 ± 0.75	2.97 ± 0.76
					0.33		0.71		0.41